Cargando…
Hemostasis testing in patients with liver dysfunction: Advantages and caveats
Due to concomitant changes in pro- and anti-coagulant mechanisms, patients with liver dysfunction have a “rebalanced hemostasis”, which can easily be tipped toward either a hypo- or a hypercoagulable phenotype. Clinicians are often faced with the question whether patients with chronic liver disease...
Autores principales: | Nguyen, Guillaume, Lejeune, Manon, Crichi, Benjamin, Frere, Corinne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611202/ https://www.ncbi.nlm.nih.gov/pubmed/34876789 http://dx.doi.org/10.3748/wjg.v27.i42.7285 |
Ejemplares similares
-
Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?
por: Frere, Corinne, et al.
Publicado: (2020) -
Burden of venous thromboembolism in patients with pancreatic cancer
por: Frere, Corinne
Publicado: (2021) -
Liver-spleen axis dysfunction in COVID-19
por: Cococcia, Sara, et al.
Publicado: (2021) -
Role of immune dysfunction in drug induced liver injury
por: Girish, Chandrashekaran, et al.
Publicado: (2021) -
De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
por: Han, Ma Ai Thanda, et al.
Publicado: (2021)